RALEIGH, N.C.--(BUSINESS WIRE)--Aug. 9, 2006--Erimos Pharmaceuticals, a rapidly emerging company focused primarily on the discovery, development and commercialization of cancer drugs, announced that leading oncology researchers Jeffrey M. Trent, Ph.D., Daniel D. Von Hoff, M.D., and Steven D. Weitman, M.D., Ph.D. have been appointed to its Scientific Advisory Board.
